Intravitreal enzyme replacement therapy (ERT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intravitreal enzyme replacement therapy (ERT), covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: Intravitreal ERT to Prevent Retinal Disease Progression in Children With CLN2 [Phase 1, Phase 2]